Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CLPP inhibitors(caseinolytic mitochondrial matrix peptidase proteolytic subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H12O7 |
InChIKeyFPLMIPQZHHQWHN-UHFFFAOYSA-N |
CAS Registry603-61-2 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Tamarixetin | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ischemic stroke | Preclinical | China | 08 Jul 2024 | |
| Staphylococcus Aureus Infections | Preclinical | China | 14 Jul 2022 |





